Palisade Bio Inc. logo

Palisade Bio Inc.

PALI | NASDAQ
Chart Builder DCF Calculator
$1.63
-$0.06 (-3.55%)
Sep 22, 2026, 2:42 PM ET · Market open

Market Data

Market Cap
$293.35M
Enterprise Value
$168.18M
Beta
1.55
Average Volume
2.8M
Shares Outstanding (Diluted)
211.38M
Shares Change YoY
4306.37%
Institutional Ownership
71.30%
Exchange
NASDAQ
ISIN
US6963894026

Price Performance

Price Change 1M
-19.1%
Price Change 3M
-12.9%
Price Change 6M
-15.5%
Price Change YTD
-32.4%
Price Change 1Y
166.2%
Price Change 3Y
-79.4%
Price Change 5Y
-99.9%
1M CAGR (ann.)
-19.9%
1Y CAGR (ann.)
182.6%
5Y CAGR (ann.)
-76.1%
All-Time CAGR
-51.1%

Valuation

PE Ratio
-3.19
Forward PE
N/A
PEG Ratio
-0.01
Forward PEG
-0.13
PS Ratio
586.70
Forward PS
6.10
PB Ratio
2.41
P/FCF Ratio
-16.13
P/Adj. FCF Ratio
-9.44
P/OCF Ratio
-18.78
EV/Sales
336.36
EV/EBIT
-5.06
EV/EBITDA
-5.06
EV/FCF
-9.25
Earnings Yield
-31.4%
FCF Yield
-6.2%
Adj. FCF Yield
-10.6%

Financial Health

Net Cash
$125.17M
Total Debt
$0
Cash & Short-Term Investments
$125.17M
Total Assets
$127.32M
Current Ratio
24.26
Quick Ratio
24.26
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-5,891.50
Altman Z-Score
30.01
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-7069.8%
EBITDA Margin
-6643.8%
Net Profit Margin
-6388.2%
FCF Margin
-3638.0%
Adj. FCF Margin
-6217.8%
SBC / Revenue
2579.8%
SBC Impact (per share)
-70.9%

Returns

Return on Assets
-25.1%
Return on Equity
-33.5%
Return on Invested Capital
-29.0%
Return on Capital Employed
-29.0%
Return on Tangible Assets
-25.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
26.0%
Revenue CAGR 5Y
50.0%
Revenue CAGR 10Y
47.9%
EPS CAGR 3Y
113.7%
EPS CAGR 5Y
21.0%
EPS CAGR 10Y
8.0%
FCF CAGR 3Y
-22.9%
FCF CAGR 5Y
-6.7%
FCF CAGR 10Y
-3.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
10.1%
Revenue Growth Next 3Y
646.1%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.06
EPS Growth Est (next Q)
-84.2%
Revenue Est (next Q)
$465.3K
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$4.50
Price Target Upside
166.3%

Cash Flow

Operating Cash Flow
$-18.19M
Free Cash Flow
$-18.19M
Adj. Free Cash Flow
$-31.09M
FCF Per Share
-$0.09
OCF Per Share
-$0.09
OCF/S Ratio
-3638.0%

Income Statement

Revenue
$500K
Gross Profit
$500K
Operating Income
$-35.35M
EBITDA
$-33.22M
Net Income
$-31.94M
EPS (Diluted)
-$0.53
Revenue / Employee
$35.71K
Profit / Employee
$-2.28M
Employees
14

© 2026 bestshares.com. All rights reserved.